(Bloomberg) -- Dr. Reddy's was rejected by an appeals court in its effort to sell generic versions of Indivior Plc's Suboxone film for opioid dependence.
Dr. Reddy's had asked that it be allowed to sell the drug while it challenges a district court ruling that halted sales while a patent-infringement case is pending. The U.S. Court of Appeals for the Federal Circuit denied that request, “without prejudicing the ultimate disposition” of the appeal.
The court earlier had agreed to an expedited appeal.
To contact the reporter on this story: Susan Decker in Washington at sdecker1@bloomberg.net
To contact the editors responsible for this story: Jon Morgan at jmorgan97@bloomberg.net, Elizabeth Wasserman
©2018 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
